RESUMO
In a double-blind cross-over study beclomethasone dipropionate inhaled as a dry-powder in a dose of 400 micrograms twice daily was compared with a conventional aerosol in a dose of 100 micrograms four times daily in 16 outpatients with chronic asthma. Each of the 2 treatments lasted for 4 weeks. There was no significant difference with respect to daily peak expiratory flow rates, symptom scores, bronchodilator usages and other lung function measurements between the 2 treatments. Tetracosactrin tests were within normal limits and no clinical oral candidiasis was observed throughout the study. In conclusion, beclomethasone dipropionate dry-power given twice daily was effective for the control of asthma and could be recommended for patients with poor drug compliance.
Assuntos
Administração por Inalação , Asma/tratamento farmacológico , Beclometasona/administração & dosagem , Ensaios Clínicos como Assunto , Método Duplo-Cego , Esquema de Medicação , Humanos , Medidas de Volume PulmonarRESUMO
A young Hong Kong Chinese male patient with fever of unknown origin is presented. The diagnosis of acquired immunodeficiency syndrome was made only 5 months after the onset of his illness. The lack of awareness of the syndrome might account for the delay in the diagnosis. The legal attitude towards homosexuality might have an adverse effect on epidemiological studies of AIDS in Hong Kong.